At what pace is the presbyopia market growing, and what is its estimated value?
The presbyopia market size has grown strongly in recent years. It will grow from $10.11 billion in 2024 to $10.70 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, rising incidences of eye disorders, growing number of geriatric populations, surging consumption of various medications, and sedentary lifestyle of people.
The presbyopia market size is expected to see strong growth in the next few years. It will grow to $13.30 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to an increase in the number of emerging markets, increasing awareness about presbyopia treatment, increasing investment in healthcare infrastructure, rising drug approvals and launches, and the growing popularity of monovision LASIK surgery. Major trends in the forecast period include advanced technologies, advancements in intraocular lens implants, development of novel presbyopia treatments, development of cost-effective non-surgical treatments, and use of artificial intelligence and machine learning.
Get Your Free Sample of The Global Presbyopia Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21261&type=smp
What are the top drivers to the rising demand in the presbyopia market?
The increasing prevalence of vision impairment is expected to propel the growth of the presbyopia market going forward. Vision impairment is a condition where a person experiences partial or complete loss of eyesight that cannot be fully corrected with glasses, contact lenses, or medical treatment. The growing prevalence of vision impairment is driven by an aging population, increasing diabetes and eye diseases, excessive screen time, and inadequate access to eye care in certain areas. Presbyopia contributes to vision impairment by reducing the eye’s ability to focus on near objects due to age-related lens stiffening, making everyday tasks like reading and screen use more challenging without corrective measures. For instance, in December 2023, according to the United Nations Development Programme (UNDP), a US-based United Nations agency, the number of individuals diagnosed with vision impairments was 19,551 in 2022 compared to 17,478 in 2021. Moreover, over 19,000 new diagnoses have been reported in just the first seven months of 2023. Therefore, the increasing prevalence of vision impairment is driving the growth of the presbyopia market.
How is the presbyopia market segmented?
The presbyopia market covered in this report is segmented –
1) By Treatment: Eyeglasses, Contact Lenses, Refractive Surgery, Lens Implants, Other Treatments
2) By Symptoms: Eye Strain, Headaches, Fatigue, Blurred Vision, Other Symptoms
3) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Eyeglasses: Bifocal Eyeglasses, Progressive Lenses, Reading Glasses, Photochromic Lenses
2) By Contact Lenses: Bifocal Contact Lenses, Multifocal Contact Lenses, Monovision Contact Lenses, Scleral Lenses
3) By Refractive Surgery: LASIK (Laser-Assisted In Situ Keratomileusis), PRK (Photorefractive Keratectomy), Conductive Keratoplasty (CK), Corneal Inlays
4) By Lens Implants: Multifocal Intraocular Lenses (IOLs), Accommodative IOLs, Extended Depth of Focus (EDOF) IOLs
5) By Other Treatments: Pharmaceutical Treatments, Corneal Cross-Linking, Near-vision Presbyopia Correction Surgery
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/presbyopia-global-market-report
Who are the top competitors in the presbyopia market?
Major companies operating in the presbyopia market are Johnson & Johnson Private Limited, AbbVie Inc., Abbott Laboratories, Novartis AG, Essilor International SAS, Carl Zeiss Meditec AG, Alcon Vision LLC, Bausch + Lomb Corporation, CooperVision Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, LENZ Therapeutics Inc., InSight Vision Incorporated, Oculis Holding AG, Orasis Pharmaceuticals Inc., Visus Therapeutics Inc., Eyenovia Inc., Atia Vision Inc.
What significant trends should we anticipate in the presbyopia market over the forecast period?
Major companies operating in the presbyopia market are focusing on advanced innovations, such as eye-responsive progressive lenses, to enhance vision and comfort for aging individuals. Eye-responsive progressive lenses are advanced multifocal lenses that adapt to eye movements, providing seamless vision correction for presbyopia at all distances. For instance, in August 2023, Essilor, a France-based company that designs, manufactures, and sells ophthalmic lenses, launched Varilux, a brand of progressive lenses for people with presbyopia. This innovation incorporates artificial intelligence (AI) to predict visual behavior based on exclusive real-life data, setting a new standard in personalized vision correction. Such technological advancements are transforming the presbyopia market, offering patients enhanced solutions to manage this age-related condition and improving overall quality of life.
Which regional trends are influencing the presbyopia market, and which area dominates the industry?
North America was the largest region in the presbyopia market in 2024. The regions covered in the presbyopia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Presbyopia Market Report 2025 Offer?
The presbyopia market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Presbyopia refers to an age-related condition where the eye’s lens loses flexibility, making it difficult to focus on close objects. It typically begins around the age of 40 and gradually worsens over time. Common solutions include reading glasses, bifocals, progressive lenses, and surgical treatments.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21261
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
